Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 7.01 is 46% below its 5-year average of 12.93, near the low end of its 5-year range (1.88–38.05).
As of the fiscal period ended Tuesday, June 30, 2026. 11.87% below its 12-month average of 7.96.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 7.01.
QUICK RATIO (ACID-TEST)
7.01
QUICK RATIO (ACID-TEST) AVG TTM
7.96
QUICK RATIO (ACID-TEST) AVG 3Y
6.43
QUICK RATIO (ACID-TEST) AVG 5Y
12.93
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-11.87%
CURRENT VS 3Y AVG
+8.99%
CURRENT VS 5Y AVG
-45.79%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
+108.98%
vs the sector median at left
LeonaBio, Inc.
Market Cap
$22.68M
Quick Ratio (Acid-Test)
7.01
TTM Avg
7.96
3Y Avg
6.43
5Y Avg
12.93
Market Cap
$23.06M
Quick Ratio (Acid-Test)
4.27
TTM Avg
1.54
3Y Avg
3.43
5Y Avg
4.75
Market Cap
$22.25M
Quick Ratio (Acid-Test)
3.25
TTM Avg
7.36
3Y Avg
6.36
5Y Avg
5.93
Market Cap
$22.00M
Quick Ratio (Acid-Test)
1.00
TTM Avg
1.04
3Y Avg
0.94
5Y Avg
0.89
Market Cap
$23.38M
Quick Ratio (Acid-Test)
3.22
TTM Avg
2.47
3Y Avg
1.96
5Y Avg
1.72
Market Cap
$24.13M
Quick Ratio (Acid-Test)
2.59
TTM Avg
2.35
3Y Avg
1.92
5Y Avg
2.36
Market Cap
$24.44M
Quick Ratio (Acid-Test)
5.69
TTM Avg
10.26
3Y Avg
14.54
5Y Avg
17.67
Market Cap
$24.60M
Quick Ratio (Acid-Test)
3.52
TTM Avg
5.18
3Y Avg
5.31
5Y Avg
5.55
Market Cap
$20.53M
Quick Ratio (Acid-Test)
3.47
TTM Avg
5.82
3Y Avg
11.52
5Y Avg
18.07
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LeonaBio, Inc. (LONA) | $22.68M | 7.01 | 7.96 | 6.43 | 12.93 |
| Rein Therapeutics Inc. (RNTX)vs › | $23.06M | 4.27 | 1.54 | 3.43 | 4.75 |
| Modular Medical, Inc. (MODD)vs › | $22.25M | 3.25 | 7.36 | 6.36 | 5.93 |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.00M | 1.00 | 1.04 | 0.94 | 0.89 |
| TherapeuticsMD, Inc. (TXMD)vs › | $23.38M | 3.22 | 2.47 | 1.96 | 1.72 |
| Kyntra Bio, Inc. (KYNB)vs › | $24.13M | 2.59 | 2.35 | 1.92 | 2.36 |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | 5.69 | 10.26 | 14.54 | 17.67 |
| InspireMD, Inc. (NSPR)vs › | $24.60M | 3.52 | 5.18 | 5.31 | 5.55 |
| NextCure, Inc. (NXTC)vs › | $20.53M | 3.47 | 5.82 | 11.52 | 18.07 |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.22M | 0.07 | 0.37 | 0.39 | 0.82 |
Quick Ratio
7.01
Excludes inventory
Current Ratio
7.01
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 7.01 |
| 2026-03-31 | 10.38 |
| 2025-12-31 | 1.88 |
| 2025-09-30 | 9.70 |
| 2025-06-30 | 10.81 |
| 2025-03-31 | 7.26 |
| 2024-12-31 | 4.18 |
| 2024-09-30 | 2.95 |
| 2024-06-30 | 3.97 |
| 2024-03-31 | 5.03 |
| 2023-12-31 | 5.37 |
| 2023-09-30 | 6.24 |
| 2023-06-30 | 8.87 |
| 2023-03-31 | 9.57 |
| 2022-12-31 | 9.68 |
| 2022-09-30 | 22.31 |
| 2022-06-30 | 26.40 |
| 2022-03-31 | 28.42 |
| 2021-12-31 | 28.07 |
| 2021-09-30 | 25.46 |
| 2021-06-30 | 38.05 |
| 2021-03-31 | 69.28 |
| 2020-12-31 | 43.66 |
| 2020-09-30 | 30.75 |
| 2020-06-30 | 15.69 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 1.70 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
